A Phase II evaluation of weekly topotecan as a single agent second line therapy in persistent or recurrent carcinoma of the cervix: A Gynecologic Oncology Group study-Reference-Cited by-同舟云学术

A Phase II evaluation of weekly topotecan as a single agent second line therapy in persistent or recurrent carcinoma of the cervix: A Gynecologic Oncology Group study

Published:2009-11 Issue:2 Volume:115 Page:285-289
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Fiorica James V.,Blessing John A.,Puneky Louis V.,Secord Angeles Alvarez,Hoffman James S.,Yamada S. Diane,Buekers Thomas E.,Bell Jeffrey,Schilder Jeanne M.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference22 articles.

1. The role of topotecan in the treatment of advanced cervical cancer;Fiorica;Gynecol. Oncol.,2003

2. American Cancer Society guidelines for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors;Saslow;CA Cancer J. Clin.,2007

3. Cancer statistics 2008;Jemal;CA Cancer J. Clin.,2008

4. Practical gynecologic oncology US.4;Berek,2005

5. Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group study;Long;J. Clin. Oncol.,2005

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Salvage (Re)radiation in Oligometastatic and Oligorecurrent Cervical Cancer;International Journal of Radiation Oncology*Biology*Physics;2022-11

2. Cervical Cancer;Fundamentals of Cancer Detection, Treatment, and Prevention;2022-05-13

3. Pembrolizumab and Chemotherapy in Cervical Cancer: A New Standard of Care?;Oncology & Haematology;2022

4. Anlotinib in Chinese Patients With Recurrent Advanced Cervical Cancer: A Prospective Single-Arm, Open-Label Phase II Trial;Frontiers in Oncology;2021-11-02

5. Management of oligo-metastatic and oligo-recurrent cervical cancer: A pattern of care survey within the EMBRACE research network;Radiotherapy and Oncology;2021-02